← Back to Patent Explorer
US4391809A Expired / Lapsed US ⏱️ 0.0 years remaining

Methods for treating psoriasis

Assignee: Warner Lambert Co LLC
•
Filing: 1980-11-13
•
Granted: 1983-07-05
•
Expires: 2000-11-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Methods for treating psoriasis by administering 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]-quinazoline, 2,4-diamino-5-chloro-6-[(3,4-dichloroanilino)methyl]-quinazoline or a pharmaceutically acceptable acid-addition salt thereof.

Inventors

  • 👤 Edward F. Elslager

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 10:27
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/495; A61K31/505

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 30 words
A method for treating psoriasis in mammals which comprises administering an antipsoriatic-effective amount of 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline, 2,4-diamino-5-chloro-6-[(3,4-dichloroanilino)methyl]quinazoline or a pharmaceutically acceptable salt thereof, to a mammal in need of said treatment.
Claim 2
Independent Claim 30 words
A method for treating psoriasis in mammals which comprises administering an antipsoriatic-effective amount of 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline, 2,4-diamino-5-chloro-6-[(3,4-dichloroanilino)methyl]quinazoline or a pharmaceutically acceptable salt thereof, to a mammal in need of said treatment.
Claim 3
Dependent Claim 20 words
The method of claim 1 wherein 0.07 mg to 7.1 mg/kg of weight per day of said compound is administered.
Claim 4
Dependent Claim 11 words
The method of claim 1 wherein said compound is 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline monoacetate.
Claim 5
Dependent Claim 11 words
The method of claim 1 wherein said compound is 2,4-diamino-5-chloro-6-[(3,4-dichloroanilino)methyl]quinazoline monoacetate.
Claim 6
Dependent Claim 12 words
The method defined in claim 1 wherein said mammal is a human.

References Cited (Backward Citations)

GB1345502A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-07-04 1987-01-03 1987-07-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-07-04 1991-01-03 1991-07-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-07-04 1995-01-03 1995-07-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag